SARS-CoV-2 is the virus that causes the COVID-19 disease (Coronovirus Disease 2019). Currently, this disease is poorly understood. Many researchers are working tirelessly to characterize this disease as well as researching treatments and/or cures, including finding a safe and effective vaccine.
T-cells are activated only by interacting with processed peptides (e.g. of SARS-CoV-2) that sit in the groove of MHC Class I and II molecules. Identifying these peptides can be used (in forms of peptide-MHC tetramers) to assess vaccine induced immunity and assist in designing potent vaccines with durable responses. COVID-19 infected cells can be recognized by T-cells only after SARS-CoV-2 peptides are processed and presented in the context of self MHCs.
We offer a vast number of peptides referenced in publications to have relevance in the immune detection pathway. We also offer antibodies and recombinant proteins found to be involved with the SARS-CoV-2 disease. MBL International is happy to assist companies and academic investigators who are actively characterizing this disease infection or developing coronavirus vaccines. Contact us for additional assistance or questions.